EDGAR Filing Documents for 0001193125-14-239287

Form 8-K - Current report:

SEC Accession No. 0001193125-14-239287

Filing Date

2014-06-17

Accepted

2014-06-17 16:55:04

Documents

Period of Report

2014-06-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d742417d8k.htm	8-K	40679
2	EX-4.1	d742417dex41.htm	EX-4.1	546421
3	EX-10.1	d742417dex101.htm	EX-10.1	178899
4	EX-10.2	d742417dex102.htm	EX-10.2	184200
5	EX-10.3	d742417dex103.htm	EX-10.3	184790
6	EX-99.1	d742417dex991.htm	EX-99.1	12721
7	EX-99.2	d742417dex992.htm	EX-99.2	15606
8	GRAPHIC	g742417ex4_1pg068.jpg	GRAPHIC	3059
9	GRAPHIC	g742417ex4_1pg069.jpg	GRAPHIC	3690
10	GRAPHIC	g742417ex4_1pg071.jpg	GRAPHIC	3744
11	GRAPHIC	g742417ex4_1pg072.jpg	GRAPHIC	3648
12	GRAPHIC	g742417ex4_1pg074.jpg	GRAPHIC	3268
13	GRAPHIC	g742417ex4_1pg075.jpg	GRAPHIC	4433
14	GRAPHIC	g742417g73e90.jpg	GRAPHIC	8454
15	GRAPHIC	g742417logo_jpmorgan.jpg	GRAPHIC	7584
	Complete submission text file	0001193125-14-239287.txt		1218084

Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139

Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400

ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)